Age Specific Hepatitis B Surface Antigen (HBsAg) and Anti-HBs Seroprevalence among Patients Admitted to a State Hospital
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 2
Abstract
Objectives: Chronic hepatitis B (CHB) infection affects 257 million people globally, Turkey is middle endemic region. According to public health data, about 2 million people in Turkey are considered to be positive for hepatitis B surface antigen (HBsAg). With effective vaccination programs, active and passive immunizations of newborns born from infected mothers and increased sanitation, the prevalence of HBsAg has declined over the past years. In Turkey, Hepatitis B virus vaccine has been included in the national vaccination schedule in 1998. In the study, our aim is to compare the seroprevalence of HBsAg and Anti-HBS by birth-date in Sungurlu State Hospital, Çorum. Materials and Methods: The results of 1,486 patients who applied to our hospital were scanned retrospectively on the electronic system. The rate of HBsAg and anti-HBs seropositivity were compared by birth-date. Results: Of 1486 cases, 737 were women and 749 were men. The median age was 38 (0-95 years). HBsAg positivity was 1.9% and anti-HBs positivity was 54.2%. All of 27 HBsAg positive patients were born before 1998. HBsAg positivity was found almost 3 times higher in the male population. Anti-HBs positivity was 41% in patients born before 1990, and 71% in those born in 1998 and after. Conclusion: Immunization is very important and effective way in chronic hepatitis B infection control and prevention. The results of our study showed a significant decrease in CHB infection with the national vaccination program. It is very essential to administer HBV vaccination to all people, especially those at risk.
Authors and Affiliations
Sibel Yıldız Kaya, Abdurrahman Kaya
Keywords
Related Articles
- EP ID EP688805
- DOI 10.4274/vhd.galenos.2020.2020.0001
- Views 109
- Downloads 0
Consideration Whether Hepatitis B Exists in Children Whose Mothers Suffer from Chronic Hepatitis B and These Mothers in Gestational Age
Objectives: Perinatal and intrauterine transmission of the hepatitis B virus (HBV) represents a major factor, leading to the development of chronic infection. This study aimed to explore the status of mothers and their c...
Evaluation of Health-Related Life Quality of Patients with Chronic Hepatitis Admitted to a Medical Faculty Hospital
Objectives: The aim of this study was to determine the life quality and related factors of patients with chronic hepatitis B and C who admitted to the Infectious Diseases Clinic of Erciyes University Medical Faculty Hosp...
Evaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection
Objectives: This study aimed to investigate the effect of treatment with direct-acting antivirals (DAAs) on the virological response and on the some parameters used to evaluate liver function in cases with chronic liver...
Investigating the Prevalence of Hepatitis Delta and Assessment of Treatment Response
Objectives: The purpose of this study was to investigate the seroprevalence of delta virus, assess the treatment outcomes of patients receiving treatment. Materials and Methods: The files of patients diagnosed with chro...
http://viralhepatitisjournal.org/archives/archive-detail/article-preview/the-effect-of-switch-treatment-on-liver-fibrosis-a/40275
Objectives: To investigate the seroprevalence of hepatitis A virus (HAV) infection in children with chronic hepatitis B virus (HBV) infection and to immunize patients who did not have anti-HAV immunoglobulin (Ig) G level...